These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3371370)

  • 21. Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide.
    Scott GC; Meier DA; Dickinson CZ
    J Nucl Med; 1995 Oct; 36(10):1843-5. PubMed ID: 7562053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship among 201T1 uptake, nuclear DNA content and clinical behavior in metastatic thyroid carcinoma.
    Nakada K; Katoh C; Morita K; Kanegae K; Tsukamoto E; Shiga T; Mochizuki T; Tamaki N
    J Nucl Med; 1999 Jun; 40(6):963-7. PubMed ID: 10452311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I].
    Feine U; Lietzenmayer R; Hanke JP; Wöhrle H; Müller-Schauenburg W
    Nuklearmedizin; 1995 Aug; 34(4):127-34. PubMed ID: 7675641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ki-67 positive fractions in benign and malignant thyroid tumours: application of flow cytometry.
    Horii A; Yoshida J; Sakai M; Okamoto S; Honjo Y; Mitani K; Hattori K; Kubo T
    Acta Otolaryngol; 1999; 119(5):617-20. PubMed ID: 10478606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of 18F-fluorodeoxyglucose uptake with the expressions of glucose transporter type 1 and Na+/I- symporter in patients with untreated papillary thyroid carcinoma.
    Moon SH; Oh YL; Choi JY; Baek CH; Son YI; Jeong HS; Choe YS; Lee KH; Kim BT
    Endocr Res; 2013; 38(2):77-84. PubMed ID: 22888973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ploidy levels in nonneoplastic and neoplastic thyroid cells.
    Auer GU; Bäckdahl M; Forsslund GM; Askensten UG
    Anal Quant Cytol Histol; 1985 Jun; 7(2):97-106. PubMed ID: 4026949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hürthle cell tumors of the thyroid. A flow cytometric DNA analysis.
    el-Naggar AK; Batsakis JG; Luna MA; Hickey RC
    Arch Otolaryngol Head Neck Surg; 1988 May; 114(5):520-1. PubMed ID: 3355687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear DNA in anaplastic thyroid carcinoma with a differentiated component.
    Galera-Davidson H; Bibbo M; Dytch HE; González-Cámpora R; Fernández A; Wied GL
    Histopathology; 1987 Jul; 11(7):715-22. PubMed ID: 3623435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear DNA content of the tall cell variant of papillary carcinoma of the thyroid gland.
    Stern Y; Medelia O; Feinmesser M; Shpitzer T; Feinmesser R; Segal K
    Ann Otol Rhinol Laryngol; 1996 Sep; 105(9):713-5. PubMed ID: 8800058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of nuclear DNA content in locally invasive and noninvasive papillary carcinoma of the thyroid gland.
    Stern Y; Lisnyansky I; Shpitzer T; Nativ O; Medalia O; Feinmesser R; Aronson M
    Otolaryngol Head Neck Surg; 1997 Nov; 117(5):501-3. PubMed ID: 9374174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
    Kim TY; Kim WB; Ryu JS; Gong G; Hong SJ; Shong YK
    Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Flow cytometric DNA content analysis in thyroid carcinoma].
    Zuo LF
    Zhonghua Zhong Liu Za Zhi; 1991 Mar; 13(2):106-9. PubMed ID: 1879287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometric DNA analysis of thyroid carcinoma.
    Tsuchiya A; Sekikawa K; Ando Y; Suzuki S; Kimijima I; Abe R
    Jpn J Surg; 1990 Sep; 20(5):510-4. PubMed ID: 2243443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is agNOR and DNA ploidy analysis useful for evaluating thyroid neoplasms?
    Camargo RS; Maeda MY; di Loreto C; Shirata NK; Anselmo Garcia E; Filho AL
    Anal Quant Cytol Histol; 2005 Jun; 27(3):157-61. PubMed ID: 16121637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma.
    Paul R
    J Nucl Med; 1987 Mar; 28(3):288-92. PubMed ID: 3469332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focal uptake of (18)F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers.
    Nam SY; Roh JL; Kim JS; Lee JH; Choi SH; Kim SY
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):135-9. PubMed ID: 17465995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endotracheal Leiomyoma Mimicking Malignancy on 18F-FDG PET/CT in a Patient With Papillary Thyroid Carcinoma.
    Hwang JP; Lee SW; Kwak JJ; Park JM
    Clin Nucl Med; 2017 Sep; 42(9):e403-e404. PubMed ID: 28639955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels.
    Wang W; Macapinlac H; Larson SM; Yeh SD; Akhurst T; Finn RD; Rosai J; Robbins RJ
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2291-302. PubMed ID: 10404792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma.
    Van den Bruel A; Maes A; De Potter T; Mortelmans L; Drijkoningen M; Van Damme B; Delaere P; Bouillon R
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1517-20. PubMed ID: 11932274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.